Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Germany maintains stem cell impetus:

This article was originally published in Clinica

Executive Summary

Germany's Robert Koch Institute (RKI) has granted a third licence for the import of human embryonic stem cells for research. It has authorised senior doctor Wolfgang-Michael Franz from the Munich University Hospital to use imported cells in research on in vitro differentiation of human embryonic stem cells in heart muscles, their purification and enrichment, and functional characterisation. Following their immunological, electrophysiological and pharmacological characterisation, the heart muscle cells will be transplanted in immune-deficient mice so that their potential value in during a heart infarct can be monitored. The RKI made its first import licence award in December 2002 (see Clinica No 1040, p 4).

You may also be interested in...

Big Win For EMA On Transparency

The European Court of Justice has confirmed the European Medicines Agency’s approach to disclosure of data submitted as part of a marketing authorization application. It is a big disappointment for industry, which nonetheless says it supports responsible data sharing and will support efforts to develop a balanced approach.

UK Biotech Financing Holds Up Despite Woodford and Brexit

Neil Woodford’s fall from grace and Brexit dragged on an otherwise buoyant sector

Dr Reddy’s Focuses On India And China

Dr Reddy’s sees its Indian domestic market and China as hot prospects as it pursues its “transformation journey” in which it is reducing its dependence on the slowing US market.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts